ESSA Pharma Stock Forecast - Polynomial Regression
| EPIXDelisted Stock | USD 0.20 0.00 0.00% |
ESSA Stock outlook is based on your current time horizon.
At this time the value of rsi of ESSA Pharma's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 13
Sell Peaked
Oversold | Overbought |
Using ESSA Pharma hype-based prediction, you can estimate the value of ESSA Pharma from the perspective of ESSA Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The Polynomial Regression forecasted value of ESSA Pharma on the next trading day is expected to be 0.64 with a mean absolute deviation of 0.23 and the sum of the absolute errors of 14.00. ESSA Pharma after-hype prediction price | USD 0.2 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ESSA |
ESSA Pharma Additional Predictive Modules
Most predictive techniques to examine ESSA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ESSA using various technical indicators. When you analyze ESSA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
ESSA Pharma Polynomial Regression Price Forecast For the 29th of January
Given 90 days horizon, the Polynomial Regression forecasted value of ESSA Pharma on the next trading day is expected to be 0.64 with a mean absolute deviation of 0.23, mean absolute percentage error of 0.09, and the sum of the absolute errors of 14.00.Please note that although there have been many attempts to predict ESSA Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that ESSA Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
ESSA Pharma Stock Forecast Pattern
| Backtest ESSA Pharma | ESSA Pharma Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of ESSA Pharma stock data series using in forecasting. Note that when a statistical model is used to represent ESSA Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.7097 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2296 |
| MAPE | Mean absolute percentage error | 0.605 |
| SAE | Sum of the absolute errors | 14.003 |
Predictive Modules for ESSA Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ESSA Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ESSA Pharma After-Hype Price Density Analysis
As far as predicting the price of ESSA Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ESSA Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ESSA Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ESSA Pharma Estimiated After-Hype Price Volatility
In the context of predicting ESSA Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ESSA Pharma's historical news coverage. ESSA Pharma's after-hype downside and upside margins for the prediction period are 0.20 and 0.20, respectively. We have considered ESSA Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ESSA Pharma is very steady at this time. Analysis and calculation of next after-hype price of ESSA Pharma is based on 3 months time horizon.
ESSA Pharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as ESSA Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ESSA Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ESSA Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 3 Events / Month | 5 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.20 | 0.20 | 0.00 |
|
ESSA Pharma Hype Timeline
ESSA Pharma is currently traded for 0.20. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. ESSA is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on ESSA Pharma is about 0.0%, with the expected price after the next announcement by competition of 0.20. About 74.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.09. Some equities with similar Price to Book (P/B) outperform the market in the long run. ESSA Pharma recorded a loss per share of 0.57. The entity last dividend was issued on the 25th of August 2025. The firm had 1:20 split on the 25th of April 2018. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.ESSA Pharma Related Hype Analysis
Having access to credible news sources related to ESSA Pharma's direct competition is more important than ever and may enhance your ability to predict ESSA Pharma's future price movements. Getting to know how ESSA Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ESSA Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| APGN | Apexigen | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TNFA | TNFA Old | (0.53) | 7 per month | 0.00 | (0.06) | 17.75 | (20.86) | 79.44 | |
| CSCI | COSCIENS Biopharma | 0.02 | 6 per month | 10.97 | 0.04 | 36.74 | (28.04) | 94.83 | |
| CRVO | CervoMed | 0.52 | 10 per month | 0.00 | (0.07) | 6.31 | (7.24) | 17.75 | |
| CHRO | CHRO Old | (0.75) | 10 per month | 5.79 | 0.04 | 10.27 | (10.69) | 68.90 | |
| SCPX | Scorpius Holdings | (2.65) | 4 per month | 43.85 | 0.26 | 900.00 | (89.29) | 4,498 | |
| BIOR | Biora Therapeutics | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KRRO | Frequency Therapeutics | (0.07) | 17 per month | 0.00 | (0.07) | 10.98 | (7.66) | 91.55 | |
| TSBX | Turnstone Biologics Corp | 0.01 | 5 per month | 3.05 | 0.03 | 6.06 | (6.06) | 21.24 |
ESSA Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ESSA Pharma stock to make a market-neutral strategy. Peer analysis of ESSA Pharma could also be used in its relative valuation, which is a method of valuing ESSA Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ESSA Pharma Market Strength Events
Market strength indicators help investors to evaluate how ESSA Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ESSA Pharma shares will generate the highest return on investment. By undertsting and applying ESSA Pharma stock market strength indicators, traders can identify ESSA Pharma entry and exit signals to maximize returns.
| Accumulation Distribution | 0.0952 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.2 | |||
| Day Typical Price | 0.2 | |||
| Market Facilitation Index | 0.02 | |||
| Relative Strength Index | 13.94 |
ESSA Pharma Risk Indicators
The analysis of ESSA Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ESSA Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting essa stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.85 | |||
| Standard Deviation | 11.4 | |||
| Variance | 129.99 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for ESSA Pharma
The number of cover stories for ESSA Pharma depends on current market conditions and ESSA Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ESSA Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ESSA Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ESSA Pharma Short Properties
ESSA Pharma's future price predictability will typically decrease when ESSA Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ESSA Pharma often depends not only on the future outlook of the potential ESSA Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ESSA Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.3 M | |
| Cash And Short Term Investments | 126.8 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in ESSA Stock
If you are still planning to invest in ESSA Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ESSA Pharma's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |